Principal Investigators

As of September 1, 2009, the NHLBI has supported hundreds of principal investigators (PIs) with American Recovery and Reinvestment (the Recovery Act) funds, using existing mechanisms, such as expansion of the research paylines from 2008 and 2009, as well as new programs created specifically for the Recovery Act, including Challenge Grants, and Grand Opportunities (GO) grants. Learn more about the scientists who are directing projects or programs supported by grants.

Below are profiles of Recovery Act-funded scientists who provided their photographs to the NHLBI. To find out more about their projects or to see all the NHLBI-funded Recovery Act projects, use the search tool on the right. If you are a PI, please consider sharing your Recovery Act story and photograph for publication on these Web pages.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z     

George Daley, M.D., Ph.D. Samuel E. Lux, IV Chair in Hematology; Director, Stem Cell Transplantation Program, Childrens Hospital Boston, Boston, Massachusetts Comparative Phenotypic, Functional, and Molecular Analysis for ESC and iPSC Administered by the NHLBI Division of Blood Diseases and Resources, Transfusion Medicine and Cellular Therapeutics Branch FY 2009 Recovery Act Funding: $1,748,199 More information about the grant

Agustin P. Dalmasso, M.D., D.M.Sc. Professor, University of Minnesota, Minneapolis, Minnesota Activation of Xenogeneic Endothelium to Resist Injury Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2009 Recovery Act Funding: $487,552 More information about the grant Additional Funding: Activation of Xenogeneic Endothelium to Resist Injury Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2010 Recovery Act Funding: $493,228 More information about the grant Total funding: $980,780

Kumuda Das, Ph.D. Associate Professor, University of Arkansas Medical Sciences Little Rock, Little Rock, Arkansas Regulation of caspase-1 by Sod2 in the heart Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2009 Recovery Act Funding: $217,500 More information about the grant Additional Funding: Regulation of caspase-1 by Sod2 in the heart Administered by the NHLBI Division of Cardiovascular Sciences, Heart Failure and Arrhythmia Branch FY 2010 Recovery Act Funding: $181,250 More information about the grant Total funding: $398,750

Salil K. Das, Sc.D., D.Sc. Professor of Biochemistry, Meharry Medical College, Nashville, Tennessee Abnormality in Gene Expression of Key Mediators of Vitamin A Action in COPD Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $73,250 More information about the grant

Karina Davidson, Ph.D. The Herbert Irving Associate Professor of Medicine and Psychiatry and Director of the Center for Behavioral Cardiovascular Health, Columbia University Medical Center, New York, New York Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2009 Recovery Act Funding: $2,155,291 More information about the grant Additional Funding: Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2010 Recovery Act Funding: $1,981,597 More information about the grant Total funding: $4,136,888

Jerry Dempsey, Ph.D. Professor Emeritus, Department of Population Health Sciences, University of Wisconsin, Madison, Wisconsin Targeted Therapies for Selected Phenotypes of Obstructive Sleep Apnea Administered by the NHLBI Division of Lung Diseases, National Center on Sleep Disorders Research FY 2009 Recovery Act Funding: $399,974 More information about the grant

Joseph DeSimone, Ph.D. William R. Kenan Jr. Distinguished Professor of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Biomimetic Approach to the Fabrication of Red Blood Cell Mimics Administered by the NHLBI Division of Blood Diseases and Resources, Transfusion Medicine and Cellular Therapeutics Branch FY 2009 Recovery Act Funding: $361,926 More information about the grant Additional Funding: Biomimetic Approach to the Fabrication of Red Blood Cell Mimics Administered by the NHLBI Division of Blood Diseases and Resources, Transfusion Medicine and Cellular Therapeutics Branch FY 2010 Recovery Act Funding: $361,994 More information about the grant Total funding: $723,920

Jorge Di Paola, M.D. Associate Professor of Pediatrics and Genetics, University of Colorado, Denver, Colorado Use of Microfluidics to Determine Hemostatic Phenotypes Administered by the NHLBI Division of Blood Diseases, Thrombosis and Hemostasis Branch FY 2009 Recovery Act Funding: $499,999 More information about the grant

Richard A. F. Dixon, Ph.D. Director, Wafic Said Department of Molecular Cardiology Research, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas Prostacyclin-Secreting Cells as Therapy for Pulmonary Artery Hypertension Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2009 Recovery Act Funding: $500,000 More information about the grant Additional Funding: Prostacyclin-Secreting Cells as Therapy for Pulmonary Artery Hypertension Administered by the NHLBI Division of Lung Diseases, Lung Biology and Disease Branch FY 2010 Recovery Act Funding: $500,000 More information about the grant Total funding: $1,000,000

Siobhan Dolan, M.D., M.P.H. Associate Professor, Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine, Montefiore Medical Center, New York, New York Ethical and Social Implications of Genetic Testing in the Case of Unexpected Deaths Administered by the NHLBI Division of Cardiovascular Sciences, Advanced Technologies and Surgery Branch FY 2009 Recovery Act Funding: $455,941 More information about the grant

Pamela Douglas, M.D., M.A.C.C., F.A.S.E., F.A.H.A. Ursula Geller Professor of Research in Cardiovascular Diseases, Duke University Medical Center, Durham, North Carolina PROMISE Trial: Clinical Coordinating Center Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2009 Recovery Act Funding: $5,566,450 More information about the grant Additional Funding: PROMISE Trial: Clinical Coordinating Center Administered by the NHLBI Division of Cardiovascular Sciences, Clinical Applications and Prevention Branch FY 2010 Recovery Act Funding: $8,046,691 More information about the grant Total funding: $13,613,141

Xiaoping Du, M.D., Ph.D. Professor, University of Illinois at Chicago, Chicago, Illinois Student and/or teacher training opportunities Administered by the NHLBI Division of Blood Diseases and Resources, Thrombosis and Hemostasis Branch FY 2009 Recovery Act Funding: $19,468 More information about the grant

Jeanne F. Duffy, M.B.A., Ph.D. Assistant Professor of Medicine, Brigham and Women's Hospital, Boston, Massachusetts Circadian & Genetic Evaluation of Extreme Sleep Timing Administered by the NHLBI Division of Lung Disases, National Center on Sleep Disorders Resarch FY 2009 Recovery Act Funding: $15,307 More information about the grant Additional Funding: Adaption of Circadian Responses to Light Treatment Administered by the NHLBI Division of Lung Disases, National Center on Sleep Disorders Resarch FY 2009 Recovery Act Funding: $698,837 More information about the grant Adaption of Circadian Responses to Light Treatment Administered by the NHLBI Division of Lung Disases, National Center on Sleep Disorders Resarch FY 2010 Recovery Act Funding: $700,768 More information about the grant Total funding: $1,414,912

Donald L. Durden, M.D., Ph.D. Aflac Professor of Pediatrics, Emory University, Atlanta, Georgia Role of Syk and Rac2 in Regulation of HIF1alpha and Neovascularization Administered by the NHLBI Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch FY 2009 Recovery Act Funding: $49,338 More information about the grant Additional Funding: Role of Syk and Rac2 in Regulation of HIF1alpha and Neovascularization Administered by the NHLBI Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch FY 2009 Recovery Act Funding: $144,412 More information about the grant Role of Syk and Rac2 in Regulation of HIF1alpha and Neovascularization Administered by the NHLBI Division of Cardiovascular Sciences, Vascular Biology and Hypertension Branch FY 2010 Recovery Act Funding: $231,750 More information about the grant Total funding: $425,500

Last Updated: March 16, 2010